"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study looking at blood and urine samples to help diagnose and treat bile duct and pancreatic cancer (TRANSBIL)
In this study, doctors want to look at blood and urine samples from people who have symptoms similar to those with bile duct and pancreatic cancer.
In most cases such symptoms are caused by other conditions. But it is important to make sure that those that are due to cancer, are diagnosed early.
They hope the results of this study will help them develop new tests to diagnose bile duct and pancreatic cancer. And find new treatments.
More about this trial
- tummy (abdominal) pain
- a swollen tummy
- loss of appetite
- weight loss
- jaundice (yellowing of the skin)
- look for certain proteins (biomarkers)
- find out why some people are more likely to develop bile duct and pancreatic cancer than others (genetic predisposition)
Who can enter
- have symptoms that could be due to bile duct or pancreatic cancer
- have been referred to the multidisciplinary diagnostic centre, gastroenterology clinic or endoscopy unit
- have a high risk of developing pancreatic cancer (your doctor can tell you more about this)
- are at least 18 years old
This is a phase 2 study.
Everyone taking part has a blood test and gives a urine sample.
As part of your routine care, you may have a test to look at the inside of your tummy (abdomen). It might be an endoscopy,
The trial team will keep your blood, urine and tissue sample for up to 10 years. They might use it in future research studies. The information about you will be removed from the samples. So no one will be able to identify you.
There are no extra hospital visits as part of this study. You have the blood test and give the urine sample during routine appointments at the hospital.
You should not have any side effects from taking part in this study.
How to join a clinical trial
Professor Steve Pereira
UCLH Cancer Collaborative
Pancreatic Cancer UK
Fiorina Pancreatic Cancer Fund (Royal Free Charity)
NIHR Clinical Research Network: North Thames